14th Jan 2025 15:56
International Biotechnology Trust PLC - London-based investment trust - Notes sale of investee Intra-Cellular Therapies Inc to Johnson & Johnson. Says price of USD132 per share, total USD14.6 billion, represents a premium of approximately 40% to its closing share price on January 10. ITCI represents 7.1% of IBT's net asset value and is its largest shareholding. Read More
